Home
Research & ReportsSep 5, 2026•1 min read

Chronic Rhinitis: Prevalence, Classification, and Standard Therapies

By the PharmaCountry team

Chronic rhinitis affects 10‑40% of people and is divided into allergic and non‑allergic types; treatment typically involves antihistamines, nasal steroids, decongestants, and leukotriene antagonists.

Chronic rhinitis (CR) presents with symptoms such as rhinorrhea, nasal congestion, itching, and sneezing. Epidemiological surveys indicate that roughly 10–40 % of the population experiences the condition, making it a common disorder. CR is categorized according to the presence of a specific IgE response to causative allergens: allergic rhinitis (AR) when IgE‑mediated, and non‑allergic rhinitis (NAR) when such a response is absent. The principal pharmacologic agents employed for both AR and NAR include antihistamines, intranasal corticosteroids, nasal decongestants, and leukotriene‑receptor antagonists.

Compiled by the PharmaCountry team · Source: KPA News

More articles

View all insights